ORIGINAL ARTICLE

JOP. J Pancreas (Online) 2003; 4(1):1-10.

Untreatable Pain Resulting from Abdominal Cancer: New Hope from Biophysics?

Giuseppe Marineo

Delta Research & Development, Research Center for Medical Bioengineering, "Tor Vergata" University. Rome, Italy

ABSTRACT

Context Visceral pain characterizing pancreatic cancer is the most difficult symptom of the disease to control and can significantly impair the quality of life which remains and increase the demand for euthanasia.

Aim To investigate a possible new method based on biophysical principles (scrambler therapy) to be used in the effective treatment of drug-resistant oncological pain of the visceral/neuropathic type.

Setting Eleven terminal cancer patients (3 pancreas, 4 colon, 4 gastric) suffering from elevated drug resistant visceral pain.

Design The trial program was related to the first ten treatment sessions. Subsequently, each patient continued to receive treatment until death.

Main outcome measures Pain measures were performed using the visual analogue scale before and after each treatment session and accompanied by diary recordings of the duration of analgesia in the hours following each single application. Any variation in pain-killing drug consumption was also recorded.

Results All patients reacted positively to the treatment throughout the whole reference period. Pain intensity showed a significant decrease (P<0.001), accompanied by a gradual rise both in the pain threshold and the duration of analgesia. Nine (81.8%) of the patients suspended pain-killers within the first 5 applications, while the remaining two (18.2%) considerably reduced the dosage taken prior to scrambler therapy. No undesirable side effects were observed. Compliance was found to be optimal.

Conclusions The preliminary results obtained using scrambler therapy are extremely encouraging, both in terms of enhanced pain control after each treatment session and in view of the possible maintenance of effectiveness over time.

Full text: HTML format  PDF format
  Look up who cited this article

References

  1. Okusaka T, Okada S, Ueno H, Ikeda M, Shimada K, Yamamoto J, et al. Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findings. Pancreas 2001; 22:279-84. [More details]

  2. Di Sebastiano P, Friess H, Di Mola FF, Innocenti P, Buchler MW. Mechanisms of pain in chronic pancreatitis. Ann Ital Chir 2000; 71:11-6. [More details]

  3. Yamamuro M, Kusaka K, Kato M, Takahashi M. Celiac plexus block in cancer pain management. Tohoku J Exp Med 2000; 192:1-18. [More details]

  4. De Conno F, Caraceni A, Aldrighetti L, Magnani G, Ferla G, Comi G, Ventafridda V. Paraplegia following coeliac plexus block. Pain 1993; 55:383-5. [More details]

  5. Abdalla EK, Schell SR. Paraplegia following intraoperative celiac plexus injection. J Gastrointest Surg 1999; 3:668-71. [More details]

  6. Iftikhar S, Loftus EV Jr. Gastroparesis after celiac plexus block. Am J Gastroenterol 1998; 93:2223-5. [More details]

  7. Vranken JH, Zuurmond WW, de Lange JJ. Increasing the efficacy of a celiac plexus block in patients with severe pancreatic cancer pain. J Pain Symptom Manage 2001; 22:966-77. [More details]

  8. Rykowski JJ, Hilgier M. Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: influence on pain relief. Anesthesiology 2000; 92:347-54. [More details]

  9. Polati E, Finco G, Gottin L, Bassi C, Pederzoli P, Ischia S. Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. Br J Surg 1998; 85:199-201. [More details]

  10. Shannon CE, Weaver W. The mathematical theory of communication. Urbana, IL: The University of Illinois, 1949. [More details]

  11. Dixon JS, Bird HA. Reproducibility along a 10 cm vertical visual analogue scale. Ann Rheum Dis 1981; 40:87-9. [More details]

  12. Flandry F, Hunt JP, Terry GC, Hughston JC. Analysis of subjective knee complaints using visual analog scales. Am J Sports Med 1991; 19:112-8. [More details]

  13. Mercadante S, Portenoy RK. Opioid poorly-responsive cancer pain. Part 1: clinical considerations. J Pain Symptom Manage 2001; 21:144-50. [More details]

  14. Mercadante S, Portenoy RK. Opioid poorly-responsive cancer pain. Part 2: basic mechanisms that could shift dose response for analgesia. J Pain Symptom Manage 2001; 21:255-64 [More details]

  15. McCormack K. Fail-Safe Mechanisms That Perpetuate Neuropathic Pain. Pain: Clin Updates 1999; VII:3. [More details]

Keywords Analgesics; Cybernetics; Drug Resistance; Hyperalgesia; Information Theory; Pain, Intractable; Pain Threshold; Palliative Care; Pancreatic Neoplasms

Correspondence Giuseppe Marineo: g.marineo@mclink.it